HOME >> MEDICINE >> NEWS
Generic vs. name brand medications

s introduce more new (and often more effective) drugs, which enjoy patent protection before they have to face competition from generics.

--The science demonstrating that generics are, in fact, bioequivalent to the name brands with which they compete has improved greatly. One argument opposing generics has traditionally been that they are not a true substitute, but now it is easier to tell if that is true scientifically, Kirking said.

--Significant restructuring in the pharmaceutical industry has led to cases where the same company makes a brand-name drug and its generic equivalent, or owns a subsidiary that does, while those companies that make only generics are merging and consolidating.

Kirking, who is professor and chair of the Department of Social and Administrative Sciences in U-M's College of Pharmacy and a research scientist in health management and policy at the U-M School of Public Health, said many people in the health care industries looked to generics as a quick-fix way to cut costs. For a number of reasons, that is not realistic, he said.

For example, a number of the most expensive medications are still under patent so no generics exist, and once the end of the patent draws near, clever pharmaceutical manufacturers reformulate---such as providing a 12-hour pill instead of one that works for four hours---and get a patent on the new and improved drug.

Kirking said therapeutic interchange might prove to play a bigger role in balancing the desire to reduce costs with the need to provide effective medication. Therapeutic interchange involves moving a patient from one drug to a different but related drug, as opposed to its chemical twin generic. This can be helpful both because very similar drugs sometimes have very different prices, as well as because one drug might not have a generic equivalent, but a related drug might. That could lead to first moving the patient from one brand-name medication to another, then t
'"/>

Contact: Colleen Newvine
cnewvine@umich.edu
734-647-4411
University of Michigan
10-Oct-2001


Page: 1 2 3

Related medicine news :

1. Generic drug use varies widely by state, study reveals
2. Generic anti-inflammatory causes significantly fewer GI complications than branded medications
3. Generics slow rising cost of prescription drugs in 2003
4. First quarter prescription drug spending: Generic drugs slow upward trend
5. Study shows patch therapy may be as effective as oral medications
6. Use of potentially inappropriate medications among elderly common in some European countries
7. Low-dose aspirin and stomach ulcer medications better for heart patients with GI complications
8. Heart patients treated by non-cardiologists less likely to receive medications
9. Conference to examine effects of dietary supplements in patients taking blood thinning medications
10. Doctors must consider potentially inappropriate medications when treating elderly
11. Adults taking eplileptic medications more likely to be unemployed

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Generic name brand medications

(Date:7/28/2015)... ... 28, 2015 , ... The Denver Foundation and Blair-Caldwell African ... Exhibited,” a photographic and narrative exploration of African American giving, which runs August ... , Denver is one of only ten cities to host “The Soul of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives with CareMed Urgent ... full support of National Immunization Awareness Month, which is the month of August. ... serious illnesses like the flu, measles, and pneumonia, adults need to get their ...
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Egg freezing ... the procedure to help ensure future fertility. As Dr. Michael Kettel explained ... freezing is an option that wasn’t available for previous generations who had to make ...
(Date:7/28/2015)... ... ... to WFTV on July 15th heroin overdose rates have increased by 270 ... statistic Orlando suffers at least one death weekly as a direct result of a ... officials are struggling to keep apace with its distribution. Officers rely on inside information ...
Breaking Medicine News(10 mins):Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3
(Date:7/28/2015)... , July 28, 2015 Dipexium ... pharmaceutical company focused on the development and commercialization ... new Locilex® microbiology data will be presented at ... Antimicrobial Agents and Chemotherapy and International Society of ... 2015) scientific meeting in San Diego, ...
(Date:7/28/2015)... 28, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... underwritten public offering of 6,666,667 shares of its ... $11.25 per share. The gross proceeds to Egalet ... $75 million, before deducting the underwriting discounts and ...
(Date:7/28/2015)... 28, 2015  ULURU Inc. (OTCQB: ULUR) announced today the ... appointment of Bradley J. Sacks to the Company,s ... Directors has determined that the 2015 Annual Meeting of the ... 10:00 a.m., Central Daylight Time at the offices of ULURU ... 75001. In accordance with the provisions of the ...
Breaking Medicine Technology:Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 2ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 3
Cached News: